Advancements in the Fight against HIV/AIDS

Riffat Mehboob
{"title":"Advancements in the Fight against HIV/AIDS","authors":"Riffat Mehboob","doi":"10.54393/pbmj.v6i10.961","DOIUrl":null,"url":null,"abstract":"For forty years, the acquired immunodeficiency syndrome (AIDS) has posed a threat to world health, resulting in unimaginable misery and fatalities. Significant advancements in the knowledge and treatment of HIV/AIDS have been accomplished since the early stages of the epidemic.  One of the most important aspects of the fight against AIDS is still stopping the spread of HIV. HIV prevention has undergone a revolutionary change with the advent of Pre-Exposure Prophylaxis (PrEP). In high-risk groups, PrEP dramatically lowers the risk of HIV infection when taken as directed. Furthermore, increasing condom usage and safe sex practices brought about by awareness-raising and education efforts have helped to reduce the number of new HIV infections in many areas. Disparities in access to preventative resources still exist, however, which highlights the need of ongoing efforts to ensure that everyone may use these treatments [1]. Treatment for HIV/AIDS has come a long way in the last several decades. The mainstay of addressing the disease is antiretroviral treatment (ART), which has changed it from a fatal illness to a chronic one. The quality of life and life expectancy of patients have improved with the development of new, more effective, and less toxic antiretroviral medications. In addition, the use of multi-drug regimens has improved viral suppression and decreased the risk of treatment resistance. Treatment plans now include targeted therapies in addition to medicine, such using CRISPR or other gene editing technologies to attack the virus at its genetic core. Additionally, the creation of long-acting injectable ART formulations has improved treatment compliance, lessening the strain on patients and medical systems [2]. Notwithstanding these developments, problems including medication resistance, treatment accessibility, and the persistence of latent viral reservoirs still exist. To get over these challenges and get one step closer to the ultimate objective of a workable treatment, research must continue. Many nations are making progress toward these goals, but there is still more to be done, especially in areas with weak healthcare systems. In addition to medical treatments, elimination calls for tackling the societal factors that contribute to the illness, such as inequality, stigma, and prejudice. Addressing these more general concerns, encouraging thorough sex education, and enabling communities to speak out for their own health are all necessary components of effective eradication initiatives. There has been a great deal of advancement in the prevention, treatment, and eradication of HIV/AIDS in the battle against the disease. To reach the ultimate objective of an AIDS-free world, however, more research and cooperation between scientists, medical professionals, legislators, and communities are required. Looking back over the last forty years, we should be encouraged by the advancements and reaffirm our commitment to making sure that HIV/AIDS does not pose a danger to global health for coming generations.","PeriodicalId":19844,"journal":{"name":"Pakistan BioMedical Journal","volume":"216 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2023-10-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Pakistan BioMedical Journal","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.54393/pbmj.v6i10.961","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

For forty years, the acquired immunodeficiency syndrome (AIDS) has posed a threat to world health, resulting in unimaginable misery and fatalities. Significant advancements in the knowledge and treatment of HIV/AIDS have been accomplished since the early stages of the epidemic.  One of the most important aspects of the fight against AIDS is still stopping the spread of HIV. HIV prevention has undergone a revolutionary change with the advent of Pre-Exposure Prophylaxis (PrEP). In high-risk groups, PrEP dramatically lowers the risk of HIV infection when taken as directed. Furthermore, increasing condom usage and safe sex practices brought about by awareness-raising and education efforts have helped to reduce the number of new HIV infections in many areas. Disparities in access to preventative resources still exist, however, which highlights the need of ongoing efforts to ensure that everyone may use these treatments [1]. Treatment for HIV/AIDS has come a long way in the last several decades. The mainstay of addressing the disease is antiretroviral treatment (ART), which has changed it from a fatal illness to a chronic one. The quality of life and life expectancy of patients have improved with the development of new, more effective, and less toxic antiretroviral medications. In addition, the use of multi-drug regimens has improved viral suppression and decreased the risk of treatment resistance. Treatment plans now include targeted therapies in addition to medicine, such using CRISPR or other gene editing technologies to attack the virus at its genetic core. Additionally, the creation of long-acting injectable ART formulations has improved treatment compliance, lessening the strain on patients and medical systems [2]. Notwithstanding these developments, problems including medication resistance, treatment accessibility, and the persistence of latent viral reservoirs still exist. To get over these challenges and get one step closer to the ultimate objective of a workable treatment, research must continue. Many nations are making progress toward these goals, but there is still more to be done, especially in areas with weak healthcare systems. In addition to medical treatments, elimination calls for tackling the societal factors that contribute to the illness, such as inequality, stigma, and prejudice. Addressing these more general concerns, encouraging thorough sex education, and enabling communities to speak out for their own health are all necessary components of effective eradication initiatives. There has been a great deal of advancement in the prevention, treatment, and eradication of HIV/AIDS in the battle against the disease. To reach the ultimate objective of an AIDS-free world, however, more research and cooperation between scientists, medical professionals, legislators, and communities are required. Looking back over the last forty years, we should be encouraged by the advancements and reaffirm our commitment to making sure that HIV/AIDS does not pose a danger to global health for coming generations.
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
抗击艾滋病毒/艾滋病的进展
四十年来,获得性免疫缺陷综合症(艾滋病)一直威胁着世界健康,造成了难以想象的痛苦和死亡。自艾滋病流行初期以来,对艾滋病毒/艾滋病的认识和治疗取得了重大进展。 抗击艾滋病最重要的方面之一仍然是阻止艾滋病毒的传播。随着暴露前预防疗法(PrEP)的出现,艾滋病毒的预防发生了革命性的变化。在高危人群中,只要按照说明服用,PrEP 就能大大降低感染艾滋病毒的风险。此外,提高认识和教育工作带来的安全套使用率和安全性行为的增加,也有助于减少许多地区新感染艾滋病毒的人数。然而,在获取预防资源方面仍然存在差距,这就凸显了持续努力确保人人都能使用这些治疗方法的必要性[1]。 在过去的几十年里,艾滋病毒/艾滋病的治疗取得了长足的进步。抗逆转录病毒疗法(ART)是治疗该疾病的主要手段,它已将该疾病从致命疾病转变为慢性疾病。随着更有效、毒性更小的新型抗逆转录病毒药物的开发,患者的生活质量和预期寿命都得到了改善。此外,多种药物治疗方案的使用提高了病毒抑制率,降低了耐药性风险。现在的治疗计划除药物治疗外,还包括靶向治疗,如使用 CRISPR 或其他基因编辑技术从基因核心攻击病毒。此外,长效注射抗逆转录病毒疗法制剂的问世提高了治疗的依从性,减轻了患者和医疗系统的负担[2]。 尽管取得了这些进展,但耐药性、治疗的可及性和潜伏病毒库的持续存在等问题依然存在。要克服这些挑战,向可行疗法的最终目标更近一步,就必须继续开展研究。许多国家正在朝着这些目标迈进,但仍有许多工作要做,尤其是在医疗保健系统薄弱的地区。除医学治疗外,消除疟疾还需要解决导致疾病的社会因素,如不平等、污名化和偏见。解决这些更普遍的问题,鼓励开展全面的性教育,让社区为自身健康发声,这些都是有效根除行动的必要组成部分。在预防、治疗和根除艾滋病毒/艾滋病的斗争中,已经取得了很大进展。然而,要实现无艾滋病世界的最终目标,科学家、医疗专业人员、立法者和社区之间还需要更多的研究与合作。回顾过去的四十年,我们应该为取得的进步感到鼓舞,并重申我们的承诺,确保艾滋病毒/艾滋病不会对后代的全球健康构成威胁。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
自引率
0.00%
发文量
0
期刊最新文献
Clinical Assessment and Demographic Insights of Lactose Intolerance Among Diarrheal Children at Hyderabad, Pakistan Exploring Genitourinary Syndrome of Menopause: Analysis of Prevalence, Determinants, and Health Impacts in Pakistani Women Patient Satisfaction from Services Provided at Low Vision Clinic in Tertiary Care Hospitals- A Cross-Sectional Study A Comparison of the Protective Effect of Pyridoxine and N-Acetylcysteine in Paracetamol Induced Hepatotoxicity in Rats Quality Assurance in Safe Handling of Hazardous Drugs Among Healthcare Workers in KSA: A Scoping Review
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1